Journal of Neural Transmission

, Volume 113, Issue 9, pp 1225–1241 | Cite as

Regional acetylcholinesterase activity and its correlation with behavioral performances in 15-month old transgenic mice expressing the human C99 fragment of APP

  • M. Dumont
  • R. Lalonde
  • J.-F. Ghersi-Egea
  • K. Fukuchi
  • C. Strazielle


In addition to Aβ plaques and neurofibrillary tangles, Alzheimer’s disease (AD) is characterized by increased brain levels of APP C-terminal fragments. In the present investigation, the cholinergic innervation in forebrain regions of transgenic mice (Tg13592) expressing the human βAPP C99 fragment was compared to that of non-transgenic controls by measuring the activity of the non-specific catabolic enzyme, acetylcholinesterase (AChE). The AchE activity of Tg13592 mice was altered in several regions implicated in the functional loop of regulation between septum and hippocampus, vulnerable in Alzheimer pathology and critically involved in cognitive functions. In particular, AChE activity was upregulated in three basal forebrain regions containing cholinergic cell bodies, prelimbic cortex, anterior subiculum, and paraventricular thalamus, but downregulated in lateral septum and reticular thalamus. The increased activity in medial septum and anterior subiculum was linearly correlated with poor performances in a spatial learning task, possibly due to cell stress mechanisms. Because of some similarities in terms of neurochemistry and behavior, this mouse model may be of use for studying prodromal AD.

Keywords: Alzheimer’s disease, acetylcholinesterase, cholinergic neuron, transgenic mice, APP C99 fragment. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Apelt, J, Kumar, A, Schliebs, R 2002Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor proteinBrain Res9531730PubMedCrossRefGoogle Scholar
  2. Atack, JR, Perry, EK, Bonham, JR, Perry, RH, Tomlinson, BE, Blessed, G, Fairbairn, A 1983Molecular forms of acetylcholinestrase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) formNeurosci Lett40199204PubMedCrossRefGoogle Scholar
  3. Bartolini, M, Bertucci, C, Cavrini, V, Andrisano, V 2003β-amyloid aggregation induced by human acetylcholinesterase: inhibition studiesBiochem Pharmacol65407416PubMedCrossRefGoogle Scholar
  4. Baskin, DS, Browning, JL, Pirozzolo, FJ, Korporaal, S, Baskin, JA, Appel, SH 1999Brain choline acetyltransferase and mental function in Alzheimer diseaseArch Neurol5611211123PubMedCrossRefGoogle Scholar
  5. Beeri, R, Andres, C, Lev-Lehman, E, Timberg, R, Huberman, T, Shani, M, Soreq, H 1995Transgenic overexpression of human acetylcholinesterase induces progressive cognitive deterioration in miceCurr Biol510631071PubMedCrossRefGoogle Scholar
  6. Bissette, G, Seidler, FJ, Nemeroff, CB, Slotkin, TA 1996High affinity choline transporter status in Alzheimer’s disease tissue from rapid autopsyAnn NY Acad Sci777197204PubMedGoogle Scholar
  7. Blusztajn, JK, Berse, B 2000The cholinergic neuronal phenotype in Alzheimer’s diseaseMet Brain Dis154564CrossRefGoogle Scholar
  8. Boncristiano, S, Calhoun, ME, Kelly, PH, Pfeifer, M, Bondolfi, L, Stalder, M, Phinney, AL, Abramoski, D, Sturchler-Pierrat, C, Enz, A, Sommer, B, Staufenbiel, M, Jucker, M 2002Cholinergic hypothesis in the APP23 transgenic mouse model of cerebral amyloidosisJ Neurosci2232343243PubMedGoogle Scholar
  9. Bowen, DM, Benton, JS, Spillane, JA, Smith, CCT, Allen, SJ 1982Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patientsJ Neurol Sci57191202PubMedCrossRefGoogle Scholar
  10. Bowen, DM, Smith, CB, White, P, Davison, AN 1976Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophiesBrain99459496PubMedGoogle Scholar
  11. Bronfman, FC, Moechars, D, Van Leuven, FW 2000Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein London mutant transgenic miceNeurobiol Dis7152168PubMedCrossRefGoogle Scholar
  12. Butcher, LL 1995Cholinergic neurons and networksPaxinos, G eds. The rat nervous systemAcademic PressNew York10031015Google Scholar
  13. Chacon, MA, Reyes, AE, Inestrosa, NC 2003Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampusJ Neurochem87195204PubMedCrossRefGoogle Scholar
  14. Choi SH, Park CH, Koo JW, Seo J-H, Kim H-S, Jeong S-J, Lee J-H, Kim SS, Suh Y-H (2001) Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxy-terminal fragment of Alzheimer’s APP in mice. FASEB J (June 18) 10.1096/fj00-0859fjeGoogle Scholar
  15. Coyle, JT, Price, DL, DeLong, MR 1983Alzheimer’s disease: a disorder of cortical cholinergic innervationScience21911841190PubMedGoogle Scholar
  16. Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet ii: 1943Google Scholar
  17. DeKosky, ST, Harbaugh, RE, Schmitt, FA, Bakay, RAE, Chui, HC, Knopman, DS, Reeder, TM, Shetter, AG, Senter, HJ, Markesbery, WR 1992Cortical biopsy in Alzheimer’s disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlationsAnn Neurol32625632PubMedCrossRefGoogle Scholar
  18. DeKosky, ST, Ikonomovic, MD, Styren, SD, Beckett, L, Wisniewski, S, Bennett, DA, Cochran, EJ, Kordower, JH, Mufson, EJ 2002Upregulation of cholinetransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairmentAnn Neurol51145155PubMedCrossRefGoogle Scholar
  19. Drachman, DA, Leavitt, J 1974Human memory and the cholinergic system – a relationship to aging?Arch Neurol30113121PubMedGoogle Scholar
  20. Dubois, B, Albert, ML 2004Amnestic MCI or prodromal Alzheimer’s disease?Lancet Neurol3246248PubMedCrossRefGoogle Scholar
  21. Ellman, GL, Courtney, KD, Andres, VJ, Featherstone, RM 1961A new and rapid colorimetric determination of acetylcholinesterase activityBiochem Pharmacol78895PubMedCrossRefGoogle Scholar
  22. Fodero, LR, Mok, SS, Losic, D, Martin, LL, Aguilar, MI, Barrow, CJ, Livett, BG, Small, DH 2004α7- Nicotinic acetylcholine receptors mediate an Aβ1–42-induced increase in the level of acetylcholinesterase in primary cortical neuronesJ Neurochem8811861193PubMedCrossRefGoogle Scholar
  23. Fodero, LR, Saez-Valero, J, McLean, CA, Martins, RN, Beyreuther, K, Masters, CL, Robertson, TA, Small, DH 2002Altered glycosylation of acetylcholinesterase in APP(sw) Tg2576 transgenic mice occurs prior to amyloid plaque depositionJ Neurochem81441448PubMedCrossRefGoogle Scholar
  24. Franklin, KBJ, Paxinos, G 1997The mouse brain in stereotaxic coordinatesAcademic PressNew YorkGoogle Scholar
  25. Frölich, L 2002The cholinergic pathology in Alzheimer’s disease: discrepancies between clinical experience and pathophysiological findingsJ Neural Transm10910031014PubMedCrossRefGoogle Scholar
  26. Fukuchi, K, Pham, D, Hart, M, Li, L, Lindsey, JR 1998Amyloid-β deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathyAm J Pathol15316871693PubMedGoogle Scholar
  27. Fukuchi, K, Sopher, B, Furlong, CE, Smith, AC, Dang, N, Martin, GM 1993Selective neurotoxicity of COOH-terminal fragments of the β-amyloid-precursor proteinNeurosci Lett154145148PubMedCrossRefGoogle Scholar
  28. Fukuchi, K, Ho, L, Younkin, SG, Kunkel, DD, Ogburn, CE, LeBoeuf, RC, Furlong, CE, Deeb, SS, Nochlin, D, Wegiel, J, Wisniewski, MH, Martin, GM 1996High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic miceAm J Pathol149219227PubMedGoogle Scholar
  29. Gomez-Ramos, P, Mufson, EJ, Moran, MA 1992Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer’s brainBrain Res569229237PubMedCrossRefGoogle Scholar
  30. Gonzalo-Ruiz, A, Sanz, JM 2002Alteration of cholinergic, excitatory amino acid and neuropeptide markers in the septum-diagonal band complex following injections of fibrillar β-amyloid protein into the retrosplenial granular cortex of the ratEur J Anat695107Google Scholar
  31. Gordon, MN, Finch, CE 1984Topochemical localization of choline acetyltransferase and acetylcholinesterase in mouse brainBrain Res308364368PubMedCrossRefGoogle Scholar
  32. Hagan, JJ, Salamone, JD, Simpson, J, Iversen, SD, Morris, RGM 1988Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularisBehav Brain Res27920PubMedCrossRefGoogle Scholar
  33. Hardy, J, Adolfsson, R, Alafuzoff, I, Bucht, G, Marcusson, J, Nyberg, P, Perdahl, E, Wester, P, Winblad, B 1985Transmitter deficits in Alzheimer’s diseaseNeurochem Int7545563CrossRefGoogle Scholar
  34. Hellweg, R, Humpel, C, Lowe, A, Hortnagl, H 1997Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis: evidence for long-term compensatory changes?Mol Brain Res45177181PubMedCrossRefGoogle Scholar
  35. Herholtz, K, Weisenbach, S, Zündorf, G, Lenz, O, Schröder, H, Bauer, B, Kalbe, E, Heiss, W-D 2004In vivo study of acetylcholinesterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer diseaseNeuroImage21136143CrossRefGoogle Scholar
  36. Inestrosa, NC, Alvarez, A, Perez, CA, Moreno, RD, Vicente, M, Linker, C, Casanueva, OI, Soto, C, Garrido, J 1996Acetylcholinesterase accelerates assembly of amyloid β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzymeNeuron16881891PubMedCrossRefGoogle Scholar
  37. Jaffar, S, Counts, SE, Ma, SY, Dadko, E, Gordon, MN, Morgan, D, Mufson, EJ 2001Neuropathology of mice carrying APPSWE and/or PS1M146L transgenes: alterations in the p75NTR cholinergic basal forebrain septohippocampal pathwayExp Neurol170227243PubMedCrossRefGoogle Scholar
  38. Jellinger, K 1988The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s diseaseJ Neurol Neurosurg Psychiatry51540543PubMedCrossRefGoogle Scholar
  39. Kalaria, RN, Kroon, SN, Grahovac, I, Perry, G 1992Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer’s diseaseNeuroscience51177184PubMedCrossRefGoogle Scholar
  40. Kelly, JF, Furukawa, K, Barger, SW, Rengen, MR, Mark, RJ, Blanc, EM, Roth, GS, Mattson, MP 1996Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neuronsProc Natl Acad Sci USA9367536758PubMedCrossRefGoogle Scholar
  41. Koelle, GB, Friendenwald, JS 1949A histochemical method for localizing cholinesterase activityProc Soc Exp Biol Med70617622PubMedGoogle Scholar
  42. Köhler, C, Srebro, B 1980Effects of lateral and medial septal lesions on exploratory behavior in the albino ratBrain Res182423440PubMedCrossRefGoogle Scholar
  43. Kugler, P, Schleicher, A, Zilles, K, Horvath, E 1993Acetylcholinesterase activity and post-lesional plasticity in the hippocampus of young and aged ratsNeuroscience5591103PubMedCrossRefGoogle Scholar
  44. Kuhl, DE, Koeppe, RA, Minoshima, S, Snyder, SE, Ficaro, EP, Foster, NL, Frey, KA, Kilbourn, MR 1999In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s diseaseNeurology52691699PubMedGoogle Scholar
  45. Lalonde, R, Dumont, M, Fukuchi, K, Strazielle, C 2002Transgenic mice expressing the human C99 terminal fragment of βAPP: effects on spatial learning, exploration, anxiety, and motor coordinationExp Gerontol3713991410CrossRefGoogle Scholar
  46. Leranth, C, Frotscher, M 1989Organization of the septal region in the rat brain: cholinergic-GABAergic interconnections and the termination of hippocampo-septal fibersJ Comp Neurol289304314PubMedCrossRefGoogle Scholar
  47. Lüth, H-J, Apelt, J, Ihunwo, AO, Arendt, T, Schliebs, R 2003Degeneration of β-amyloid-associated cholinergic structures in transgenic APPSW miceBrain Res9771622PubMedCrossRefGoogle Scholar
  48. Lyness, SA, Zarow, C, Chui, HC 2003Neuron loss in key cholinergic and aminergic nuclei in Alzheimer’s disease: a meta-analysisNeurobiol Aging24123PubMedCrossRefGoogle Scholar
  49. Marutle, A, Warpman, U, Bogdanovic, N, Lannfelt, L, Nordberg, A 1999Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutationJ Neurochem7211611169PubMedCrossRefGoogle Scholar
  50. McNamara, RK, Skelton, RW 1993The neuropharmacological and neurochemical basis of place learning in the Morris water mazeBrain Res Rev183349PubMedCrossRefGoogle Scholar
  51. McPhie, DL, Lee, RKK, Eckman, CB, Olstein, DH, Durham, ST, Yager, D, Younkin, SG, Wurtman, RJ, Neve, RL 1997Neuronal expression of beta-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid beta and cytoplasmic domainsJ Biol Chem2722474324746PubMedCrossRefGoogle Scholar
  52. Melo, JB, Agosinho, P, Oliveira, CR 2003Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by beta-peptideNeurosci Res45117127PubMedCrossRefGoogle Scholar
  53. Mesulam, MM 2004The cholinergic lesion of Alzheimer’s disease: pivotal factor or side show?Learning and Memory114349PubMedCrossRefGoogle Scholar
  54. Mesulam, MM, Geula, C 1988Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferaseJ Comp Neurol275216240PubMedCrossRefGoogle Scholar
  55. Mesulam, MM, Mufson, EJ, Wainer, BH, Levey, AI 1983Central cholinergic pathways in the rat: an overview based on the alternative nomenclature (Ch1–Ch6)Neuroscience1011851201PubMedCrossRefGoogle Scholar
  56. Moran, PM, Higgins, LS, Cordell, B, Moser, PC 1995Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid protein precursor proteinProc Natl Acad Sci USA9253415345PubMedCrossRefGoogle Scholar
  57. Morris, JC 2002Challenging assumptions about Alzheimer’s disease: mild cognitive impairment and the cholinergic hypothesisAnn Neurol51143144PubMedCrossRefGoogle Scholar
  58. Morris, JC, Storandt, M, Miller, JP, McKeel, DW, Price, JL, Rubin, EH, Berg, L 2001Mild cognitive impairment represents early-stage Alzheimer’s diseaseArch Neurol58397405PubMedCrossRefGoogle Scholar
  59. Morris, RGM, Schenk, F, Tweedie, F, Jarrard, LE 1990Ibotenate lesions of the hippocampus and/or subiculum: dissociating components of allocentric spatial learningEur J Neurosci210161028PubMedCrossRefGoogle Scholar
  60. Oster-Granite, ML, McPhie, DL, Greenan, J, Neve, RL 1996Age-dependent neuronal and synaptic degeneration in mice transgenic for the C-terminus of the amyloid precursor proteinJ Neurosci1667326741PubMedGoogle Scholar
  61. Paxinos, G, Watson, C 1986The rat brain in stereotaxic coordinatesAcademic PressSan DiegoGoogle Scholar
  62. Perry, EK, Gibson, PH, Blessed, G, Perry, RH, Tomlinson, BE 1977Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissueJ Neurol Sci34247265PubMedCrossRefGoogle Scholar
  63. Price, JL 1995ThalamusPaxinos, G eds. The rat nervous systemAcademic PressNew York629645Google Scholar
  64. Reader, TA, Strazielle, C 1999Quantitative autoradiography of monoamine uptake sites and receptors in rat and mouse brainBoulton, AABaker, GBBateson, AN eds. Neuromethods, cell neurobiology techniquesHumana PressTotowa151CrossRefGoogle Scholar
  65. Sberna, G, Saez-Valero, J, Beyreuther, K, Masters, CL, Small, DH 1997The β-amyloid protein of Alzheimer’s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cellsJ Neurochem6911771184PubMedGoogle Scholar
  66. Sberna, G, Saez-Valero, J, Li, Q-X, Czech, C, Beyreuther, K, Masters, CL, McLean, CA, Small, DH 1998Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer’s diseaseJ Neurochem71723731PubMedGoogle Scholar
  67. Schmued, LC, Hopkins, KJ 2000Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degenerationBrain Res874123130PubMedCrossRefGoogle Scholar
  68. Segal, M, Greenberger, V, Israeli, M, Biegon, A 1988A correlation between regional acetylcholinesterase activity in rat brain and performance in a spatial taskBehav Brain Res30215219PubMedCrossRefGoogle Scholar
  69. Shinotoh, H, Namba, H, Fukushi, K, Nagatsuka, S, Tanaka, N, Aotsuka, A, Ota, T, Tanada, S, Irie, T 2000Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer’s disease: a positron emission tomography studyAnn Neurol48194200PubMedCrossRefGoogle Scholar
  70. Slotkin, TA, Nemeroff, CB, Bissette, G, Seidler, FJ 1994Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer’s disease. Evidence from rapid autopsy studiesJ Clin Invest94696702PubMedCrossRefGoogle Scholar
  71. Strazielle, C, Dumont, M, Fukuchi, K, Lalonde, R 2004Transgenic mice expressing the human C99 terminal fragment of βAPP: effects on cytochrome oxidase activity in skeletal muscle and brainJ Chem Neuroanat27237246PubMedCrossRefGoogle Scholar
  72. Suh, YH, Checler, F 2002Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer’s diseasePharmacol Rev54469525PubMedCrossRefGoogle Scholar
  73. Tago, H, McGeer, PL, McGeer, EG 1987Acetylcholinesterase fibers in the development of senile plaquesBrain Res40363369CrossRefGoogle Scholar
  74. Talesa, VN 2001Acetylcholinesterase in Alzheimer’s diseaseMech Ageing Dev12219611969PubMedCrossRefGoogle Scholar
  75. Teaktong, T, Graham, A, Court, J, Perry, R, Jaros, E, Johnson, M, Hall, R, Perry, E 2003Alzheimer’s disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytesGlia41207211PubMedCrossRefGoogle Scholar
  76. Tourtellotte, WG, Van Hoesen, GW, Hyman, BT, Tikoo, RK, Damasio, AR 1990Alz-50 immunoreactivity in the thalamic reticular nucleus in Alzheimer’s diseaseBrain Res515227234PubMedCrossRefGoogle Scholar
  77. Wang, H-Y, Lee, DHS, Davis, CB, Shank, RP 2000Amyloid peptide Aβ1–42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptorsJ Neurochem7511551161PubMedCrossRefGoogle Scholar
  78. Wevers, A, Burghaus, L, Moser, N, Witter, B, Steinlein, OK, Schütz, U, Achnitz, B, Krempel, U, Nowacki, S, Pilz, K, Stoodt, J, Lindstrom, J, De Vos, RAI, Jansen Steur, ENH, Schröder, H 2000Expression of nicotinic acetylcholine receptors in Alzheimer’s disease: postmortem investigations and experimental approachesBehav Brain Res113207215PubMedCrossRefGoogle Scholar
  79. Whitehouse, PJ, Price, DL, Struble, RG, Clark, AW, Coyle, JT, Delon, MR 1982Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrainScience21512371239PubMedGoogle Scholar
  80. Wong, TP, Debeir, T, Duff, K, Cuello, AC 1999Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenesJ Neurosci1927062716PubMedGoogle Scholar
  81. Wong-Riley, MTT 1989Cytochrome oxidase: an endogenous metabolic marker for neuronal activityTrends Neurosci1294101PubMedCrossRefGoogle Scholar
  82. Wright, CI, Geula, C, Mesulam, M-M 1993Protease inhibitors and indolamines selectively inhibit cholinesterase in the histopathologic structures of Alzheimer diseaseProc Natl Acad Sci USA90683686PubMedCrossRefGoogle Scholar
  83. Yang, L, He, H-Y, Zhang, X-J 2002Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cellsNeurosci Res42261268PubMedCrossRefGoogle Scholar
  84. Yu, W-F, Guan, Z-Z, Bogdanovic, N, Nordberg, A 2005High selective expression of α7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer’s disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaquesExp Neurol192215225PubMedCrossRefGoogle Scholar
  85. Zatta, P, Ibn-Lkhayat-Idrissi, M, Zambenedetti, P, Kilyen, M, Kiss, T 2002In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesteraseBrain Res Bull594145PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • M. Dumont
    • 1
  • R. Lalonde
    • 1
  • J.-F. Ghersi-Egea
    • 2
  • K. Fukuchi
    • 3
  • C. Strazielle
    • 4
  1. 1.Université de Rouen, Faculté de Médecine et de Pharmacie, INSERM U614RouenFrance
  2. 2.Université de Lyon-Laennec, INSERM U433, Faculté de MédecineLyonFrance
  3. 3.Department of Biomedical and Therapeutic SciencesUniversity of Illinois College of MedicinePeoriaUSA
  4. 4.Université Henri Poincaré, Nancy I, Laboratoire de Pathologie Moléculaire et Cellulaire des Nutriments, INSERM U724, and Service de Microscopie Electronique, Faculté de MédecineVandoeuvre-les-NancyFrance

Personalised recommendations